Literature DB >> 7488127

Cloning and characterization of the murine activin receptor like kinase-1 (ALK-1) homolog.

X Wu1, C E Robinson, H W Fong, J S Crabtree, B R Rodriguez, B A Roe, J M Gimble.   

Abstract

Multiple serine/threonine kinases were detected in a bone marrow stromal cell line. One of these, the murine activin receptor like kinase-1 (ALK-1) homolog was cloned and sequenced. The expressed recombinant protein (62 kDa) was consistent in size with that predicted by the cDNA (58.6 kDa). On Western blots, a goat polyclonal antibody detected the native ALK-1 protein in bone marrow stromal cells, lung, brain, kidney and spleen. Two protein species of 60 kDa and 72-76 kDa were detected. Glycosylation events or alternative splicing may account for the larger protein specie.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488127     DOI: 10.1006/bbrc.1995.2594

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.

Authors:  D Marchesan; T M Cox; P B Deegan
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

Review 3.  ALK1 as an emerging target for antiangiogenic therapy of cancer.

Authors:  Sara I Cunha; Kristian Pietras
Journal:  Blood       Date:  2011-04-05       Impact factor: 22.113

4.  Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.

Authors:  Laurens A van Meeteren; Midory Thorikay; Simon Bergqvist; Evangelia Pardali; Corrado Gallo Stampino; Dana Hu-Lowe; Marie-José Goumans; Peter ten Dijke
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

5.  Transforming growth factor-β stimulates Smad1/5 signaling in pulmonary artery smooth muscle cells and fibroblasts of the newborn mouse through ALK1.

Authors:  Huili Zhang; Lili Du; Ying Zhong; Kathleen C Flanders; Jesse D Roberts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-06-22       Impact factor: 5.464

6.  Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK.

Authors:  Ying Ying; Takashi Ueta; Shanshan Jiang; Hui Lin; Yuanyuan Wang; Demetrios Vavvas; Rong Wen; Ye-Guang Chen; Zhijun Luo
Journal:  Oncotarget       Date:  2017-05-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.